Community-based effort to boost lung cancer screening with navigators
Official title: A Community Health Intervention to Improve Lung Cancer Screening Uptake in Community Health Centers
Run by Baystate Medical Center · NCT07168629 · Data updated 2026-11-12
This project tests whether a navigator-led program in community health centers can help people eligible for lung cancer screening and support tobacco treatment use.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 50 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Baystate Medical Center Academic / other |
| Locations | 1 site (Springfield, Massachusetts) |
| Status | Recruiting |
| Started | May 10, 2026 |
| Main results expected | February 1, 2028 |
| Study ends | August 1, 2028 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07168629 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 50–80 who are potentially eligible for LCS and receive care at Mason Square, High Street, or Brightwood community health centers, and who speak English or Spanish.
✕Probably not a fit
Individuals not eligible for lung cancer screening based on age or smoking history, or those already screened recently, may not benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot randomized study partners with community health centers to test a multi-component navigator intervention aimed at increasing lung cancer screening uptake and tobacco treatment among adults aged 50–80 who smoke or recently quit. Participants are assigned to enhanced usual care, a community health worker–delivered program, or the same program delivered by a trained lay navigator. The intervention includes patient outreach, shared decision-making about screening, tobacco treatment counseling, and help overcoming logistical barriers to care. The work lays the groundwork for a larger trial to compare CHW- and lay navigator–led approaches for improving access to screening and tobacco treatment.
Why it matters
Potential benefit: If successful, participants may have improved access to lung cancer screening and better support for quitting tobacco.
How similar studies have gone: Previous CHW- and navigator-led interventions in cancer prevention have shown promise in reducing barriers and increasing access to screening in similar settings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults between the age of 50 and 80. * Potentially eligible for LCS according to the Electronic Health Record smoking history. * Receive their primary care at Mason Square, High Street, or Brightwood community health centers. * English- or Spanish- speaking. Exclusion Criteria: * Not eligible for lung cancer screening based on age (age \< 50 or \> 80 years) or smoking history (has not smoked more than 20 pack-years of tobacco cigarettes or quit more than 15 years ago). * Have received a lung cancer screen in the past.
Where it's running
-
Baystate Health
Springfield, Massachusetts, United States Recruiting
Study contacts
- Study coordinator: Eduardo R Nunez, MD, MS
- Email: Eduardo.nunez2@baystatehealth.org
- Phone: 1-855-794-5864
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
ePRO in advanced lung cancer: emotional distress, brain metastasis, and symptom burden
This study tests how patients with advanced lung cancer—some with brain metastases—report emotional distress and symptoms over time using electronic questionnaires.
-
Urine VOC Test to Detect Lung Cancer in Never Smokers
A urine test that looks for volatile compounds is tested to see if it can help detect lung cancer in adults who have never smoked.
-
SI-B036 safety test in advanced and metastatic solid tumors
This early-phase study checks whether SI-B036 is safe and tolerable in adults with advanced or metastatic solid cancers who have had prior therapy.
-
One extra structured CBT session to help cancer patients quit smoking
This trial tests whether adding one CBT-based smoking-cessation session to standard brief counseling helps cancer patients quit smoking cigarettes.
-
Guaraná Supplement for Cancer-Related Fatigue in People Undergoing Treatment
This study tests whether taking guaraná capsules helps reduce cancer-related fatigue and improve quality of life in adults with breast, lung, colorectal, or gastric cancer who are actively receiving treatment.
-
Relapse-prevention counseling added to standard care for cancer patients who quit smoking at diagnosis
This trial tests whether adding one structured CBT-based relapse-prevention session helps cancer patients who have remained smoke-free since diagnosis stay abstinent longer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.